1. Home
  2. TBPH vs FMNB Comparison

TBPH vs FMNB Comparison

Compare TBPH & FMNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBPH
  • FMNB
  • Stock Information
  • Founded
  • TBPH 2013
  • FMNB 1887
  • Country
  • TBPH United States
  • FMNB United States
  • Employees
  • TBPH N/A
  • FMNB N/A
  • Industry
  • TBPH Biotechnology: Pharmaceutical Preparations
  • FMNB Major Banks
  • Sector
  • TBPH Health Care
  • FMNB Finance
  • Exchange
  • TBPH Nasdaq
  • FMNB Nasdaq
  • Market Cap
  • TBPH 699.0M
  • FMNB 567.7M
  • IPO Year
  • TBPH N/A
  • FMNB N/A
  • Fundamental
  • Price
  • TBPH $14.40
  • FMNB $14.75
  • Analyst Decision
  • TBPH Strong Buy
  • FMNB Buy
  • Analyst Count
  • TBPH 4
  • FMNB 2
  • Target Price
  • TBPH $23.00
  • FMNB $15.50
  • AVG Volume (30 Days)
  • TBPH 543.4K
  • FMNB 83.7K
  • Earning Date
  • TBPH 11-11-2025
  • FMNB 10-22-2025
  • Dividend Yield
  • TBPH N/A
  • FMNB 4.62%
  • EPS Growth
  • TBPH N/A
  • FMNB N/A
  • EPS
  • TBPH 0.26
  • FMNB 1.34
  • Revenue
  • TBPH $77,205,000.00
  • FMNB $169,441,000.00
  • Revenue This Year
  • TBPH $79.82
  • FMNB $20.80
  • Revenue Next Year
  • TBPH N/A
  • FMNB $8.33
  • P/E Ratio
  • TBPH $55.89
  • FMNB $10.98
  • Revenue Growth
  • TBPH 24.49
  • FMNB 0.20
  • 52 Week Low
  • TBPH $7.88
  • FMNB $11.58
  • 52 Week High
  • TBPH $14.55
  • FMNB $16.29
  • Technical
  • Relative Strength Index (RSI)
  • TBPH 72.80
  • FMNB 52.36
  • Support Level
  • TBPH $13.47
  • FMNB $14.83
  • Resistance Level
  • TBPH $14.42
  • FMNB $15.15
  • Average True Range (ATR)
  • TBPH 0.41
  • FMNB 0.24
  • MACD
  • TBPH -0.05
  • FMNB -0.06
  • Stochastic Oscillator
  • TBPH 86.11
  • FMNB 9.64

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About FMNB Farmers National Banc Corp.

Farmers National Banc Corp is a one-bank holding company engaged in financial activities, including securities underwriting and dealing, insurance agency and underwriting activities, and merchant banking activities. It operates in the domestic banking, trust, retirement consulting, insurance, and financial management industries. The company has two operating segments of business; the Bank segment, and the Trust segment, out of which the majority of the company's revenue is derived from the bank segment.

Share on Social Networks: